Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Maximize Value

Developing strategies to accelerate the shift from volume to value

A model of payment transformation in Southeast Michigan is gaining traction.

Editor, Health & Life Sciences, Oliver Wyman
Senior Vice President, Health Care Value, BCBSM
Senior Vice President, Network and Provider Partnerships, BCBSM

Cost as an Investment (Not an Inconvenience)

But it's always been done this way. Until now.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman

Here's how we did on last year's predictions and what emerging trends to expect next.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Manager, Health & Life Sciences, Oliver Wyman

What's around the bend for partnerships, politics, personalization, and technology.

Chairman & CEO, Welltok
Partner, Health & Life Sciences, Oliver Wyman

By 2030, 20% of the US will be over 65. Boomers represent the biggest, most lucrative MA growth segment.

Co-Founder and CEO, Clover Health
CEO, Alignment Healthcare
Former President of Government Business, Anthem/BCBSM, Senior Adviser, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

We've made big impact over the past ten years. But, our work heading into 2020 and beyond is far from over.

Founder and CEO, Aledade

The Illusions and Temptations of Successful M&A

What we can learn from industries beyond healthcare where M&A activities have generated greater returns.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

The possibilities of new Asian health ecosystems and care models are here (and, they’re here to stay).

Regional Head, Education, Research, Healthcare & Not for Profit, Amazon Web Services
Managing Director, Asia Health and Global Health Innovation, AXA

How not to be fooled, and why the old way is old news.

Principal, Health & Life Sciences, Oliver Wyman

Analysis on how Cigna/Express Scripts and Aetna/CVS may benefit consumers.

Senior Principal, Oliver Wyman
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman

Insights in your inbox

Subscribe